EPISODE · Dec 9, 2024 · 24 MIN
Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases
from Citeline Podcasts · host Norstella
In this episode of the In Vivo podcast, Peter Flynn, CEO of Arialys Therapeutics, discusses the exciting field of autoimmune neuropsychiatry and the company’s monoclonal antibody, which it is investigating for the treatment of a rare condition called anti-NMDA receptor encephalitis and potentially other indications.
Embed this episode
NOW PLAYING
Arialys Therapeutics: Treating Autoimmune Neuropsychiatric Diseases
0:00
24:07
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 24 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on December 9, 2024.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!